PMGC Holdings (ELAB) Payables (2022 - 2026)
PMGC Holdings (ELAB) posted Payables of $3.2 million for Q1 2026, up 304.19% sequentially from $782633.0 in Q4 2025, and up 722.89% YoY from $384418.0 in Q1 2025.
PMGC Holdings (ELAB) Payables (2022 - 2026) Analysis & Trends
PMGC Holdings has reported Payables for 5 years, with the latest figure at $3.2 million in Q1 2026.
- Quarterly Payables rose 722.89% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (up 722.89% YoY) and the FY2025 annual result came in at $782633.0, up 62.71% from the prior year.
- Payables climbed to $3.2 million in Q1 2026 per ELAB's latest filing, from $782633.0 in the prior quarter.
- Over five years, Payables peaked at $1.2 billion in Q3 2023 and troughed at $271567.0 in Q2 2025.
- A 5-year average of $102.9 million and a median of $642902.5 in 2023 frame the typical range for Payables.
- The sharpest annual moves came in 2024 and 2026: Payables sank 99.9% in 2024, then surged 722.89% in 2026.
- Over 5 years, Payables stood at $313159.0 in 2022, then jumped by 60.68% to $503172.0 in 2023, then declined by 4.41% to $481001.0 in 2024, then jumped by 62.71% to $782633.0 in 2025, then surged by 304.19% to $3.2 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $3.2 million, $782633.0, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 108.02 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 428.93 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 35.57 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 622.65 Mn |
| 10 | PMGC Holdings | 3.01 Mn | -15.78 Mn | 385,691.00 | 2.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.16 Mn |
| Dec 31, 2025 | 782,633.00 |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 271,567.00 |
| Mar 31, 2025 | 384,418.00 |
| Dec 31, 2024 | 481,001.00 |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 489,468.00 |
| Dec 31, 2023 | 503,172.00 |
| Sep 30, 2023 | 1.23 Bn |
| Dec 31, 2022 | 313,159.00 |